Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films
Febuxostat (FXS) is a potent antigout drug with poor water solubility and relative high first-pass effect leading to moderate oral bioavailability (<49%). This study aimed to increase FXS solubility and bioavailability by optimizing sublingual fast-dissolving films (SFs) containing a selected FXS...
Main Authors: | Basant A. Habib, Amina S. Abd El-Samiae, Boushra M. El-Houssieny, Randa Tag |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1927247 |
Similar Items
-
Comparison of Efficacy of Febuxostat with Allopurinol in Lowering Serum Urate Levels
by: Muhammad Osama Osama
Published: (2017-06-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
by: Andreas Jordan, et al.
Published: (2018-05-01) -
Cardiovascular safety of febuxostat. Analysis of the CARES study
by: M. S. Eliseev
Published: (2018-12-01) -
Efficacy and safety of febuxostat in elderly female patients
by: Mizuno T, et al.
Published: (2014-09-01)